ClinicalTrials.gg
Drug

Irbesartan clinical trials

Also written Avapro.

studies test it
70
open now
3
in phase 3
20
first study started
1995

How each study uses Irbesartan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Irbesartan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Sept 1997 · AVAPRO · NDA 020757 (FDA, Drugs@FDA)
European Union
26 Aug 1997 · Aprovel · EMEA/H/C/000141 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Irbesartan
45
Aprovel
4
Irbesartan (Aprovel)
3
Irbesartan 150mg
2

Brand

Avapro
6
Karvea
1

In one entry with another drug

Given together, or one or the other

Irbesartan/Amlodipine
4
Irbesartan/hydrochlorothiazide
4
Irbesartan and Hydrochlorothiazide
2
Irbesartan/HCTZ
2

Studies by the year they started

70 studies that test it; most in 2005 (9)

Studies that test Irbesartan, by start year
YearStudies
19951
20023
20037
20047
20059
20068
20076
20083
20096
20123
20132
20142
20151
20163
20191
20201
20224
20231
20262

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
5
Phase 3
20
Phase 4
29
No phase
12

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 43 · Other 27

Sanofi (24) · Bristol-Myers Squibb (6) · Handok Inc. (4) · Roxane Laboratories (4) · Assistance Publique - Hôpitaux de Paris (2) · Technische Universität Dresden (2) · ANRS, Emerging Infectious Diseases (1) · Alnylam Pharmaceuticals (1)

Often tested with

Tested in the same studies.

Hydrochlorothiazide (11) · Amlodipine (10) · Ramipril (4) · Atorvastatin (3) · Valsartan (3) · Olmesartan Medoxomil (2) · Olmesartan (2) · Zilebesiran (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Irbesartan.

Studies

Open first, then newest update. How each study uses Irbesartan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 70

See all 70 studies that test Irbesartan →

Given beside what is tested · 7 — Irbesartan is usual care or a partner of the new treatment
As the comparator · 13 — what is tested is compared with Irbesartan

Codes

What other systems call Irbesartan · ClinicalTrials.gg INT006715

  • MeSH (NLM) D000077405IrbesartanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) J0E2756Z7NIRBESARTANConfirmed FDA, NLM, Wikidata
  • RxNorm 83818Confirmed FDA, Wikidata
  • Wikidata Q947266irbesartanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29130IrbesartanOne source FDA
  • DrugBank DB01029One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.